• Study on Etrinabdione for Patients with Peripheral Arterial Disease: Evaluating Safety and Tolerability

    Not recruiting

    2 1 1
    Investigated Diseases:
    Investigated Drugs:
    Spain
  • Study on Niraparib for Maintenance Treatment in Patients with Advanced Ovarian Cancer After Initial Chemotherapy Response

    Not recruiting

    3 1 1
    Belgium Czechia Denmark Finland France Germany +6
  • Study of erdafitinib versus chemotherapy (gemcitabine or mitomycin) for patients with high-risk non-muscle-invasive bladder cancer with FGFR mutations who failed BCG therapy

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    France Germany Poland
  • Study on the Safety and Effectiveness of Gefurulimab for Adults with Generalized Myasthenia Gravis

    Not recruiting

    3 1
    Investigated Diseases:
    Investigated Drugs:
    Austria Denmark France Germany Italy The Netherlands +3
  • Study on the Effects of Semaglutide in Patients with Non-Alcoholic Steatohepatitis (NASH) and Fibrosis Stages 2 or 3

    Not recruiting

    3 1 1
    Investigated Drugs:
    Austria Belgium Bulgaria Croatia Czechia Denmark +12
  • Study Comparing TAR-200 and Chemotherapy for Patients with High-Risk Non-Muscle-Invasive Bladder Cancer After BCG Treatment

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    Belgium France Germany Italy Poland Romania +1
  • Study of LY3541860 and Meglumine Gadoterate for Adults with Relapsing Multiple Sclerosis

    Not recruiting

    2 1 1
    Investigated Diseases:
    France Germany Italy Latvia Lithuania Poland +1
  • Study Comparing Asciminib with Other Drug Combinations for Adults with Newly Diagnosed Chronic Myeloid Leukemia

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    Austria Belgium Bulgaria Czechia Denmark Finland +9
  • Study on the Safety and Effectiveness of Garetosmab for Adults with Fibrodysplasia Ossificans Progressiva

    Not recruiting

    3 1
    Investigated Drugs:
    Finland France Italy The Netherlands Poland Spain
  • Study on the Effects of Amikacin Liposome Inhalation, Azithromycin, and Ethambutol in Adults with Newly Diagnosed Nontuberculous Mycobacterial Lung Infection

    Not recruiting

    3 1 1
    Investigated Diseases:
    Austria Belgium Denmark France Germany Greece +5

powered by